Diabetes, Technology & Therapeutics (DTT), under the leadership of Editor-in-Chief Dr. Satish Garg, is the only peer-reviewed journal delivering information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes to optimize patient care.
Learn more about this journal.
Jessica Castle, MD
Associate Professor, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University
Associate Editor, Diabetes Technology & Therapeutics
Patty Telgener
VP of Reimbursement
Emerson Consultants
Claudia Graham
Former Senior Vice President of Global Access
Dexcom
In this podcast our expert faculty Patty Telgener, VP of Reimbursement of Emerson Consultants and Claudia Graham, former Senior VP of Global Access of Dexcom discuss tips on CGM coding. Topics discussed include an overview of coding for professional CGM (codes 95250 and 95251), personal CGM (code 95249), and how the COVID-19 pandemic has impacted CGM coding.
Jessica Castle, MD
Associate Professor, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University
Associate Editor, Diabetes Technology & Therapeutics
Gregory Forlenza, MD
Assistant Professor of Pediatrics
The Barbara Davis Center
In this podcast our expert faculty Dr. Gregory Forlenza of The Barbara Davis Center discusses the use and benefits of automated insulin delivery in children and adults. Topics discussed include commercially available automated insulin delivery systems in the U.S. and globally, systems currently in development, the role of interoperability, including integrated continuous glucose monitoring (iCGM).
Jessica Castle, MD
Associate Professor, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University
Associate Editor, Diabetes Technology & Therapeutics
Daniel DeSalvo, MD
Assistant Professor of Pediatrics
Director of Strategic Collaboration, Texas Children’s Diabetes & Endocrine Care Center
Type 1 Diabetes Clinic Lead
Section of Pediatric Diabetes & Endocrinology
Baylor College of Medicine/Texas Children's Hospital
Lori Laffel, MD, MPH
Chief, Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center
Senior Investigator, Section Head on Clinical, Behavioral and Outcomes Research
Professor of Pediatrics, Harvard Medical School
In this podcast our expert faculty, Drs. Lori Laffel and Daniel DeSalvo discuss the use and benefits of real-time CGM in young children, adolescents, and young adults. Topics discussed include clinical study outcomes, ways to increase utilization in these age ranges, and benefits of real-time CGM.
Jessica Castle, MD
Associate Professor, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University
Associate Editor, Diabetes Technology & Therapeutics
Janet B. McGill, MD
Professor of Medicine
Division of Endocrinology, Metabolism and Lipid Research
Washington University School of Medicine
Viral Shah, MD
Assistant Professor of Medicine & Pediatrics
Barbara Davis Center for Diabetes, Adult Clinic
School of Medicine
University of Colorado Anschutz Medical Campus
In this podcast Dr. Viral Shah and Dr. Janet McGill discuss the use of RT-CGM in the senior population. Topics discussed include benefits of RT-CGM, addressing barriers and improving utilization in seniors using technology, and clinical study outcomes.
Jessica Castle, MD
Associate Professor, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University
Associate Editor, Diabetes Technology & Therapeutics
Diana Isaacs, MD
Endocrinology Clinical Pharmacy Specialist
CGM Program Coordinator
Department of Endocrinology, Diabetes & Metabolism
Cleveland Clinic Diabetes Center
Daniel Katselnik, MD
Endocrinologist
Diabetes and Metabolism Specialists
In this podcast we will be discussing the benefits and value of professional CGM. We will be reviewing the differences between professional and personal CGM, blinded and unblinded use cases, as well as the basics of CGM data interpretation and reimbursement. We will highlight Dexcom G6 Professional System and discuss candidates for personal vs. professional CGM.
Nicholas B. Argento MD FACE
Diabetes Technology Director
Maryland Endocrine and Diabetes Center
Jessica Castle, MD
Associate Professor, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University
Associate Editor, Diabetes Technology & Therapeutics
Keri Leone MS, RD, CDE
Sr. Director, Global Medical Science & Education, Dexcom
John B. Welsh, MD, PhD
Senior Manager Medical Writer, Dexcom
Continuous glucose monitoring (CGM) is a widely used tool to help improve outcomes in people living with diabetes. In this podcast, we discuss how to use CGM data to assess glycemic control, how to maximize the benefits of CGM alarms, and the impacts of Dexcom Share/Follow and Clarity use.
Viral Shah, MD
Assistant Professor of Medicine & Pediatrics
Barbara Davis Center for Diabetes
University of Colorado Anschutz Medical Campus
R. Paul Wadwa, MD
Associate Professor of Pediatrics
Barbara Davis Center for Diabetes
University of Colorado Anschutz Medical Campus
In episode #3 of the Dexcom Podcast Series, Dr. Paul Wadwa and Dr. Viral Shah review the Dexcom G6 CGM accuracy data in patients with type 1 diabetes and insulin-treated patients with type 2 diabetes. They discuss the accuracy of this CGM, accuracy of hypo and hyperglycemia alerts, and a brief explanation of CGM lag time, FDA classification for device approval, and the significance of an interoperable CGM.
Irl Hirsch
Professor of Medicine,
University of Washington School of Medicine
William Polonsky, PhD, CDE
President, Behavioral Diabetes Institute
Associate Clinical Professor, University of California, San Diego
In episode #2 of the Dexcom Podcast Series, Dr. Irl Hirsch and Dr. William Polonsky review the lack of data of CGM in patients with type 1 diabetes receiving multiple daily injections. They discuss the GOLD Study main results and delve deeper into the further analysis of hypoglycemia reduction at night and during the day, and how this improved hypoglycemia-related confidence when using CGM.
Andrew Ahmann, MD
Professor of Medicine and Director of Harold Schnitzer Diabetes Health Center,
Oregon Health & Science University
In episode #1 of The Dexcom Podcast Series, Dr. Satish Garg, Editor-in-Chief of Diabetes Technology and Therapeutics introduces Dr. Andrew Ahmann and work featured in his manuscript entitled Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.
Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes.
The consortium for glucose monitoring education is dedicated to optimizing diabetes therapy and improving clinical outcomes using real-time (RT) personal and professional CGM in adult and pediatric populations. View webcasts and earn CME/CPE credits.